| PRSS1 |
PRSS1, TRP1, TRY1, TRYP1: Trypsin-1 precursor |
REG3A |
REG3A, HIP, PAP, PAP1: Regenerating islet-derived protein 3 alpha precursor |
0.445 |
Evidence |
|
| PRSS1 |
PRSS1, TRP1, TRY1, TRYP1: Trypsin-1 precursor |
REG1B |
REG1B, REGL: Lithostathine 1 beta precursor |
0.445 |
Evidence |
|
| C8G |
C8G: Complement component C8 gamma chain precursor |
AFM |
AFM, ALB2, ALBA: Afamin precursor |
0.445 |
Evidence |
|
| C8B |
C8B: Complement component C8 beta chain precursor |
SERPINA10 |
SERPINA10, ZPI, UNQ707/PRO1358: Protein Z-dependent protease inhibitor precursor |
0.445 |
Evidence |
|
| C8B |
C8B: Complement component C8 beta chain precursor |
F5 |
F5: Coagulation factor V precursor |
0.445 |
Evidence |
|
| C8A |
C8A: Complement component C8 alpha chain precursor |
F5 |
F5: Coagulation factor V precursor |
0.445 |
Evidence |
|
| C8A |
C8A: Complement component C8 alpha chain precursor |
LPA |
LPA: Apolipoprotein(a) precursor |
0.445 |
Evidence |
|
| CSF1R |
CSF1R, FMS: Macrophage colony-stimulating factor 1 receptor precursor |
CD33 |
CD33, SIGLEC3: Myeloid cell surface antigen CD33 precursor |
0.445 |
Evidence |
|
| ASGR2 |
ASGR2: Asialoglycoprotein receptor 2 |
FGFR4 |
FGFR4, JTK2, TKF: Fibroblast growth factor receptor 4 precursor |
0.445 |
Evidence |
|
| NEF3 |
NEFM, NEF3, NFM: Neurofilament medium polypeptide |
SPTAN1 |
IPI00413728 |
0.445 |
Evidence |
|
| NEFL |
NEFL, NF68, NFL: Neurofilament light polypeptide |
GFAP |
GFAP: Glial fibrillary acidic protein |
0.445 |
Evidence |
|
| CD2 |
CD2, SRBC: T-cell surface antigen CD2 precursor |
CD69 |
CD69: Early activation antigen CD69 |
0.445 |
Evidence |
|
| CD2 |
CD2, SRBC: T-cell surface antigen CD2 precursor |
ITGB7 |
ITGB7: Integrin beta-7 precursor |
0.445 |
Evidence |
|
| CD2 |
CD2, SRBC: T-cell surface antigen CD2 precursor |
HLA-G |
HLA-G, HLA-6.0, HLAG: HLA class I histocompatibility antigen, alpha chain G prec |
0.445 |
Evidence |
|
| S100A9 |
S100A9, CAGB, CFAG, MRP14: Protein S100-A9 |
LYN |
LYN: Tyrosine-protein kinase Lyn |
0.445 |
Evidence |
|
| S100A9 |
S100A9, CAGB, CFAG, MRP14: Protein S100-A9 |
S100A11 |
MLN70, S100A11, S100C: Protein S100-A11 |
0.445 |
Evidence |
|
| C2 |
C2: Complement C2 precursor |
CFHR2 |
CFHR2, CFHL2, FHR2, HFL3: Complement factor H-related protein 2 precursor |
0.445 |
Evidence |
|
| C2 |
C2: Complement C2 precursor |
F5 |
F5: Coagulation factor V precursor |
0.445 |
Evidence |
|
| C2 |
C2: Complement C2 precursor |
LPA |
LPA: Apolipoprotein(a) precursor |
0.445 |
Evidence |
|
| RB1 |
RB1: Retinoblastoma-associated protein |
SKIIP |
SNW1, SKIIP, SKIP: SNW domain-containing protein 1 |
0.445 |
Evidence |
|
| RB1 |
RB1: Retinoblastoma-associated protein |
GTF2B |
GTF2B, TF2B, TFIIB: Transcription initiation factor IIB |
0.445 |
Evidence |
|
| CD1A |
CD1A: T-cell surface glycoprotein CD1a precursor |
CD3G |
CD3G, T3G: T-cell surface glycoprotein CD3 gamma chain precursor |
0.445 |
Evidence |
|
| SERPINA7 |
SERPINA7, TBG: Thyroxine-binding globulin precursor |
C8B |
C8B: Complement component C8 beta chain precursor |
0.445 |
Evidence |
|
| SSB |
SSB: Lupus La protein |
HNRPA0 |
HNRPA0: Heterogeneous nuclear ribonucleoprotein A0 |
0.445 |
Evidence |
|
| CLEC3B |
CLEC3B, TNA: Tetranectin precursor |
LGALS3BP |
LGALS3BP, M2BP: Galectin-3-binding protein precursor |
0.445 |
Evidence |
|